Table 4.

Main KEGG pathways significantly relating to major hubs

Term	Pathway	Count	Pop Hits	P Value
hsa05200	Pathways in cancer	41	393	6.63E−27
hsa05161	Hepatitis B	27	145	1.73E−23
hsa05205	Proteoglycans in cancer	23	200	3.70E−15
hsa04151	PI3K-Akt signaling pathway	23	345	2.43E−10
hsa05166	HTLV-I infection	19	254	2.58E−09
hsa05206	MicroRNAs in cancer	19	286	1.70E−08
hsa05152	Tuberculosis	18	177	6.66E−11
hsa04510	Focal adhesion	18	206	7.34E−10
hsa05219	Bladder cancer	17	41	1.18E−20
hsa04066	HIF-1 signaling pathway	17	96	4.41E−14
hsa05160	Hepatitis C	17	133	8.19E−12
hsa04010	MAPK signaling pathway	17	253	1.11E−07
hsa05210	Colorectal cancer	16	62	7.74E−16
hsa05212	Pancreatic cancer	16	65	1.78E−15
hsa05215	Prostate cancer	16	88	2.09E−13
hsa05142	Chagas disease (American trypanosomiasis)	16	104	2.67E−12
hsa05145	Toxoplasmosis	16	110	6.18E−12
hsa05164	Influenza A	16	174	4.54E−09
hsa05223	Non-small cell lung cancer	15	56	4.75E−15
hsa04012	ErbB signaling pathway	15	87	3.24E−12